Ischaemic preconditioning and TNF-α-mediated preconditioning is associated with a differential cPLA2 translocation pattern in early ischaemia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 6, 2008, Pages 403-413

  Loos, B ^a   Smith, R ^a   Engelbrecht, A M ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOCYTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ANIMALS; APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROUP IV PHOSPHOLIPASES A2; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MEMBRANE GLYCOPROTEINS; MICE; MUSCLE FIBERS; MYOBLASTS; MYOCARDIAL ISCHEMIA; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46049114843     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.05.002     Document Type: Article

References (39)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
2. Pasupathy S., and Homer-Vanniaskam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 106-115
3. Mann D.L. The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. J. Card. Fail 2 (1996) 165-172
4. Meldrum D.R., Dinarello C.A., Shames B.D., Cleveland J.C., Cain B.S., et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 98 (1998) 214-218
5. Meldrum D.R. Tumor necrosis factor in the heart. Am. J. Physiol. 274 (1998) 577-595
6. Mann D.L. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 65 (2003) 81-101
7. Belosjorow S., Schulz R., Dorge H., Schade F.U., and Heusch G. Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am. J. Physiol. 277 (1999) H2470-H2475
8. Lecour S., Smith R.M., Woodward B., Opie L.H., Rochette L., et al. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J. Mol. Cell Cardiol. 34 (2002) 509-518
9. 2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem. J. 15 (2002) 23-32
10. Hirabayashi T., and Shimizu T. Localization and regulation of cytosolic phospholipase A2. Biochim. Biophys. Acta 1488 (2000) 124-138
11. Luschen S., Adam D., Ussat S., Kreder D., Schneider-Brachert W., et al. Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochem. Biophys. Res. Commun. 274 (2000) 506-512
12. Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ. Res. 95 (2004) 1140-1153
13. MacEwan D.J. Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett. 379 (1996) 77-81
14. Esumi K., Nishida M., Shaw D., Smith T.W., and Marsh J.D. NADH measurements in adult rat myocytes during simulated ischemia. Am. J. Physiol. 260 (1991) H1743-H1752
15. Kitakaze M., Fong M., Yoshitake M., Minamino T., Node K., et al. Vesnarinone inhibits adenosine uptake in endothelial cells, smooth muscle cells and myocytes, and mediates cytoprotection. J. Mol. Cell Cardiol. 29 (1997) 3413-3417
16. 2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410 (1997) 49-53
17. Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol. Ther. 94 (2002) 123-135
18. Belosjorow S., Bolle I., Duschin A., Heusch G., and Schulz R. TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H927-H930
19. Sapirstein A., and Bonventre J.V. Specific physiological roles for cytosolic phospholipase A2 as defined by gene knockouts. Biochim. Biophys. Acta 144 (2000) 139-148
20. Debnath J., Baehrecke E., and Kroemer G. Does autophagy contribute to cell death?. Autophagy 1 2 (2005) 66-74
21. Piot C.A., Martini J.F., Bui S.K., and Wolfe C.L. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo. Cardiovasv. Res. 44 (1999) 542-563
22. Yang Z., Zingarelli B., and Szabo C. Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13 (2000) 60-66
23. Freude B., Masters T.N., Robicsek F., Fokin A., Kostin S., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J. Mol. Cell Cardiol. 32 (2000) 197-208
24. Engelbrecht A.M., Niesler C., Page C., and Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res. Cardiol. 99 (2004) 338-350
25. Taketo M.M., and Sonoshita M. Phospolipase A2 and apoptosis. Biochim. Biophys. Acta 1585 (2002) 72-76
26. Grewal S., Herbert S.P., Ponnambalam S., and Walker J.H. Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA. FEBS J. 272 (2005) 1278-1290
27. Murakami M., Das S., Kim Y.J., Cho W., and Kudo I. Perinuclear localization of cytosolic phospholipase A(2)alpha is important but not obligatory for coupling with cyclooxygenases. FEBS Lett. 546 (2003) 251-256
28. van Rossum G.S., Drummen G.P., Verkleij A.J., Post J.A., and Boonstra J. Activation of cytosolic phospholipase A2 in Her14 fibroblasts by hydrogen peroxide: a p42/44(MAPK)-dependent and phosphorylation-independent mechanism. Biochim. Biophys. Acta 1636 (2004) 183-195
29. Fatima S., Khandekar Z., Parmentier J.H., and Malik K.U. Cytosolic phospholipase A2 activation by the p38 kinase inhibitor SB203580 in rabbit aortic smooth muscle cells. JPET 298 (2001) 331-338
30. 2+ homeostasis during hemorrhagic shock in rat. J. Mol. Med. 77 (1999) 8-13
31. Draper D., Harris V., Culver C., et al. Calcium and its role in the nucleartranslocation and activation of cytosolic phospholipase A2 in cells rendered sensitive to TNF-induced apoptosis. J. Immunol. 172 (2004) 2416-2423
32. Sheridan A., Sapirstein A., Lemieux N., et al. Nuclear translocation of cytosolicphospholipase A2 is induced by ATP depletion. J. Biol. Chem. 276 (2001) 29899-29905
33. Vogt A.M., Elsasser A., Pott-Beckert A., et al. Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis. Mol. Cell. Biochem. 278 (2005) 223-232
34. Pardue S., Rapoport S.I., and Bosetti F. Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum. Brain Res. Mol. Brain Res. 116 (2003) 106-114
35. 2+ transients and contraction of adult rat cardiomyocytes. Am. J. Physiol. Cell Physiol. 282 (2002) C1339-C1347
36. Engelbrecht A.M., Engelbrecht P., Genade S., Niesler C., and Page C. Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. J. Mol. Cell Cardiol. 39 (2005) 940-954
37. Mackay K., and Mochly-Rosen D. Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc. Res. 50 (2001) 65-74
38. Hazen S.L., Ford D.A., and Gross R.W. Activation of a membrane-associated phospholipase A2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate. J. Biol. Chem. 266 (1991) 5629-5633
39. Evans J.H., Spencer D.M., Zweifach A., and Leslie C.C. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J. Biol. Chem. 276 (2001) 30150-30160